Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
BIO
Valuace
70
Růst
15
Zdraví
70
Cena
$ 306.69
Dnes
--8.53 (-2.65%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
8.3B
Obrat
3B
Zisk
1B
Aktiva
10B
Dluh
1B
ROE
0%
ROA
0%
PE
9
PS
3
Cena 1R
211-374
⌀ Cena
276.61
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-02-2026
Poslední dividenda

Profil

Společnost Bio-Rad Laboratories, Inc. vyrábí a distribuuje produkty pro výzkum v oblasti biologických věd a klinické diagnostiky ve Spojených státech, Evropě, Asii, Kanadě a Latinské Americe. Společnost působí v segmentech Life Science a Clinical Diagnostics. Segment Life Science vyvíjí, vyrábí a uvádí na trh řadu činidel, přístrojů a laboratorních nástrojů, které se používají při výzkumných technikách, při biofarmaceutických výrobních procesech a při potravinových testech. Zaměřuje se na vybrané segmenty trhu věd o živé přírodě v oblasti proteomiky, genomiky, biofarmaceutické výroby, buněčné biologie a bezpečnosti potravin. Tento segment slouží univerzitám a lékařským fakultám, průmyslovým výzkumným organizacím, vládním agenturám, výrobcům léčiv, biotechnologickým výzkumníkům, výrobcům potravin a laboratořím pro testování potravin. Segment klinické diagnostiky navrhuje, vyrábí, prodává a podporuje testovací systémy, informační systémy, testovací sady a specializované kontroly kvality pro klinické laboratoře na trhu diagnostiky. Tento segment nabízí činidla, nástroje a software, které řeší specifické mezery na trhu diagnostických testů in vitro. Své výrobky prodává do referenčních laboratoří, nemocničních laboratoří, státních novorozeneckých screeningových zařízení, kancelářských laboratoří lékařů a transfuzních laboratoří. Kromě toho společnost nabízí produkty a systémy pro oddělení složitých chemických a biologických materiálů, jakož i pro identifikaci, analýzu a čištění složek. Společnost nabízí své produkty prostřednictvím svých přímých prodejců, jakož i prostřednictvím distributorů, zástupců, makléřů a dalších prodejců. Bio-Rad Laboratories, Inc. byla založena v roce 1952 a sídlí v Hercules v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
7700
Založení
1980-02-27
Adresa
1000 Alfred Nobel Drive
CEO
Norman D. Schwartz

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues2,583.22,583.22,566.52,671.32,802.22,922.52,545.62,311.72,290.12,160.22,068.22,019.42,175.02,132.72,069.22,073.51,927.1
Cost of Revenues1,243.31,239.61,187.61,239.91,234.91,281.91,107.81,054.71,065.7972.8930.1897.8996.5954.2908.2895.6835.6
Gross Profit1,339.91,343.61,378.91,431.31,567.31,640.71,437.81,257.01,224.41,187.41,138.11,121.71,178.51,178.51,161.01,177.91,091.5
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues693.2653.0651.6585.4667.5649.7638.5610.8681.2632.1
Cost of Revenues348.0309.6306.3279.4325.6293.8282.8284.4315.3296.4
Gross Profit345.2343.4345.3306.0341.9355.9355.1326.5365.9335.7
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0226.9256.9271.7226.6202.7199.2250.3205.9193.0220.3211.0214.0186.4172.3
Selling General & Admin Expenses0.00.00.0820.6827.8879.6800.3824.6833.3808.9816.7762.0808.2798.1682.9696.3635.2
Depreciation & Amortization195.3205.4151.6145.9181.9160.6162.6160.3138.1148.7142.9131.8149.9147.2130.4121.0108.9
Total Operating Expenses1,110.91,077.51,109.91,089.21,084.71,151.21,026.91,027.31,032.51,059.21,022.6955.01,028.51,009.0896.9882.7807.5
Operating Income229.1270.5269.0365.7482.6489.4411.0229.7-108.6116.753.2166.7150.0169.5264.1295.2284.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.062.243.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0205.9201.2
Depreciation & Amortization52.454.250.638.149.349.146.647.853.048.1
Total Operating Expenses282.3278.1268.2282.3283.6291.4253.6274.5268.1244.7
Operating Income61.966.477.123.758.364.5101.552.097.890.9
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income95.695.582.0100.958.018.918.230.526.619.114.710.113.513.411.40.00.0
Interest Expense49.049.048.949.438.11.621.923.424.021.921.921.722.161.349.353.163.7
Other Expense766.4725.0-2,611.5-1,215.8-5,186.94,948.74,496.72,031.4339.4-8.4-52.00.83.74.216.7-6.30.0
IBT995.5995.5-2,342.5-850.1-4,704.35,438.14,907.62,261.1507.497.841.6145.8131.6112.4231.6235.8220.3
Income Tax Expense235.6235.6-498.3-212.8-1,076.71,192.21,101.4502.4146.4-16.913.432.842.734.662.357.733.3
Net Income759.9759.9-1,844.2-637.3-3,627.54,245.93,806.31,758.7361.0114.728.1113.188.877.8169.2178.2185.5
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income31.013.714.736.215.915.516.634.016.817.3
Interest Expense12.112.312.612.012.212.212.312.312.412.4
Other Expense867.3-497.5336.959.7-967.2797.2-2,887.8439.1330.646.2
IBT929.2-431.1414.083.4-908.9861.6-2,786.3491.1428.4137.1
Income Tax Expense209.2-89.296.219.4-193.1208.4-620.8107.278.730.8
Net Income720.0-341.9317.864.0-715.8653.2-2,165.5383.9349.7106.3
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-21.82$-121.79$142.61$128.13$58.93$12.10$4.12$0.88$3.74$3.08$2.72$5.85$6.39$6.70
EPS Diluted$0.00$0.00$0.00$-21.82$-121.79$140.83$126.47$58.27$11.94$4.07$0.88$3.71$3.05$2.69$5.78$6.29$6.59
Shares Outstanding27.027.328.229.229.829.829.829.829.829.729.429.228.928.628.328.027.7
Diluted Shares Outstanding27.027.328.229.229.830.230.230.230.230.029.629.429.128.928.628.528.2
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$12.15$3.65
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$12.14$3.64
Shares Outstanding27.026.927.227.928.027.928.428.528.829.1
Diluted Shares Outstanding27.026.927.228.028.028.028.428.528.829.2
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents407.3488.1404.0434.2470.8662.2660.7431.5383.8456.3457.5413.3331.6463.4574.2906.6
Short Term Investments1,214.81,176.41,203.31,362.0404.7334.5459.5418.8376.7387.7332.9284.4277.4457.7238.9118.6
Total Cash & ST Investments1,622.11,664.51,607.11,796.2875.5996.71,120.2850.4760.5844.0790.5697.6608.9921.1813.11,025.2
Accounts Receivable455.3452.5489.0494.6423.5419.4392.7393.1464.8372.3391.5377.6422.7398.7398.7388.0
Inventory803.7760.0780.5719.3572.2622.3554.0584.3594.8525.0490.2471.0501.3448.4433.5398.1
Other Current Assets175.2153.3171.7147.8117.8101.5113.3196.5156.9103.2105.4170.1215.0156.6152.9157.6
Total Current Assets3,056.33,030.33,048.33,158.01,989.12,139.82,180.22,024.41,977.11,844.51,777.61,716.41,747.91,924.81,798.21,975.3
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents397.8369.3521.4488.1410.4406.9433.3404.0457.9390.0
Short Term Investments1,022.81,004.51,139.01,176.41,212.11,209.21,212.41,208.91,306.71,338.2
Total Cash & ST Investments1,420.61,373.81,660.41,664.51,622.51,616.11,645.71,612.91,764.61,728.2
Accounts Receivable474.2469.9424.7452.5461.9445.5444.8500.9457.4491.6
Inventory783.2798.8790.1760.0804.3803.7783.4780.5775.8776.6
Other Current Assets164.0168.6161.4153.3166.9190.9187.1154.0154.6148.0
Total Current Assets2,842.02,811.13,036.63,030.33,055.63,056.33,060.93,048.33,146.83,138.9
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment715.2688.6723.7679.6695.8693.5701.2508.7493.5488.6437.7428.8429.4416.9349.5333.6
Goodwill412.1410.5413.6406.5347.3291.9264.1219.8506.1477.1495.9500.4517.8495.4468.9364.0
Intangible Assets307.1293.6320.5332.1253.9199.5145.5125.1174.1161.6214.0254.2266.2260.9259.5203.9
Long-Term Investments5,100.04,839.27,696.68,830.914,387.09,561.14,638.22,655.71,027.7830.8719.8389.3377.9294.0-11.2-13.0
Other Long-Term Assets-780.7101.994.4-1,770,386.4-3,058,977.3-2,076,698.3-997,707.4-553,169.1-222,115.5-222,871.1-233,408.6-154,864.9-162,060.224.1220.7185.9
Total Long-Term Assets6,632.26,333.89,250.710,343.715,786.710,832.85,828.73,579.22,294.92,006.01,933.91,624.91,640.91,506.81,298.61,087.4
Total Assets9,688.49,364.112,299.113,501.717,775.812,972.68,008.95,603.64,272.03,850.53,711.53,341.33,388.83,431.63,096.83,062.8
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment0.0740.1681.7688.6719.2715.2711.3723.7711.4687.9
Goodwill578.7581.6414.6410.5415.1412.1412.8413.6407.0411.5
Intangible Assets388.4396.9296.1293.6307.3307.1313.6320.5314.2328.7
Long-Term Investments5,058.25,576.54,994.24,839.26,002.65,099.68,018.47,698.57,218.27,311.1
Other Long-Term Assets829.1107.9103.7101.9103.698.292.9-1,475,400.6-1,271.1-1,301.8
Total Long-Term Assets6,854.47,403.06,490.36,333.87,547.86,632.29,548.99,250.78,749.28,839.4
Total Assets9,696.410,214.19,526.99,364.110,603.59,688.412,609.912,299.111,895.911,978.2
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable126.7122.3144.6329.8418.9362.3287.1264.5306.8296.5280.2128.6148.5131.0129.1113.4
Short-Term Debt42.042.940.40.50.51.8426.20.50.40.30.30.31.81.80.8233.2
Other Current Liabilities445.0271.4302.0186.2210.7224.9158.5157.4167.2143.5131.1291.2310.8302.2304.9137.7
Current Liabilities487.0467.8522.8568.7680.9631.5905.5449.3502.7471.3441.4446.8487.5461.2459.1666.6
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable128.8139.3137.9122.3122.2126.7102.8144.6111.9149.5
Short-Term Debt38.140.642.542.944.142.040.540.939.637.0
Other Current Liabilities310.6332.8289.1271.4288.0282.4288.9-35,421.7302.7320.9
Current Liabilities522.3548.9506.6467.8497.9487.0466.2522.8558.2582.0
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt1,190.31,331.81,354.91,197.710.512.313.6438.9434.6434.2435.7435.7435.6732.4731.7731.1
Capital Leases160.4173.1205.9189.9223.4223.1223.10.00.00.00.00.00.00.00.00.0
Def. Tax Liability878.5818.01,475.51,770.53,059.12,076.8997.8553.2222.2222.9233.5154.9162.1115.185.559.7
Total Liabilities2,909.72,794.83,557.93,886.44,108.73,092.72,253.81,587.81,341.71,263.71,221.01,156.11,202.11,414.91,352.41,522.2
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt1,357.21,365.91,327.01,331.81,344.01,350.71,359.21,364.51,365.91,355.1
Capital Leases192.6204.10.0173.1186.8160.4169.3175.1167.2146.8
Def. Tax Liability872.6961.0840.8818.01,076.1878.51,541.01,475.51,369.61,401.8
Total Liabilities2,959.63,085.42,847.52,794.83,115.62,909.73,558.83,557.93,479.73,531.3
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings7,479.17,416.49,260.69,898.213,507.29,268.05,470.83,722.11,830.41,836.21,808.11,695.01,606.11,523.71,359.91,181.7
Comprehensive Income-451.4-538.2-336.0-466.8-175.6282.5-87.3-47.0738.8417.8382.1218.9340.7274.9198.7198.0
Total Common Equity6,778.86,569.38,741.19,615.313,667.19,879.95,755.14,015.72,930.32,586.82,490.52,185.22,186.72,016.21,743.91,536.7
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings7,456.37,798.27,480.47,416.48,132.27,479.19,644.59,260.68,910.98,804.7
Comprehensive Income-166.8-154.1-409.8-538.2-315.3-451.4-426.0-336.0-497.6-372.9
Total Common Equity6,736.87,128.76,679.46,569.37,487.96,778.89,051.18,741.18,416.28,446.9
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt1,392.71,374.71,405.41,198.211.014.1439.8439.4435.0434.5436.0436.0437.4734.2732.5964.3
Book Value6,778.86,569.38,741.19,615.313,667.19,879.95,755.14,015.72,930.32,586.82,490.52,185.22,186.72,016.71,744.41,540.5
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value6,736.87,128.76,679.46,569.37,487.96,778.89,051.18,741.18,416.28,446.9
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-1,325.6759.9-1,844.2-637.3-3,627.54,245.93,806.31,758.7361.0114.728.1113.188.877.8169.3178.0186.9
Depreciation & Amortization184.7205.4151.60.0137.3133.8138.1134.2138.1148.7142.9131.8149.9147.2130.4121.0108.9
Stock-Based Compensation62.40.062.361.360.951.241.635.627.823.419.717.014.913.713.210.710.2
Change Working Capital214.2275.6-620.8-127.6-407.013.951.755.4-37.3-155.5-10.4-51.821.7-66.6-11.5-54.6-72.4
Change In Accounts Receivable39.219.616.211.4-87.4-20.4-15.01.659.7-64.112.5-39.011.1-24.24.4-20.1-37.0
Change In Accounts Payable-43.7-0.1-40.9-51.8-94.269.9124.710.6-45.67.830.128.6-9.933.219.00.00.0
Change In Inventories-22.268.98.50.0-158.846.1-52.124.2-12.9-47.7-57.1-54.25.8-33.4-2.2-44.0-15.9
Other Non-cash Items1,969.9-879.22,706.31,078.65,272.4-3,737.1-3,420.7-1,490.4-323.013.566.5-9.9-2.0-7.4-15.46.10.2
Cash from Operations345.60.00.0374.9194.4656.5575.3457.9285.5103.9216.4186.2273.3175.5278.9259.8225.9
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income720.0-341.9-120.164.0-715.8653.2-2,165.5383.9349.7106.3
Depreciation & Amortization52.454.2-38.138.149.338.936.437.153.037.3
Stock-Based Compensation0.00.0-15.315.316.415.615.015.316.215.9
Change Working Capital260.7-14.4-43.643.657.0220.7-679.554.0-93.9360.5
Change In Accounts Receivable3.94.2-37.237.2-9.4-7.4-4.437.4-20.226.4
Change In Accounts Payable-1.3-33.3-29.829.8-16.52.217.8-44.420.6-37.7
Change In Inventories51.613.617.9-17.924.515.2-22.4-8.815.4-6.4
Other Non-cash Items-1,058.4511.4333.6-31.1717.3-764.82,891.2-420.5-318.8-406.4
Cash from Operations0.00.00.00.00.00.00.00.081.097.7
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-168.8-157.6-165.6-156.7-114.2-120.8-98.9-98.5-129.8-115.1-141.6-113.4-136.5-113.7-154.2-103.3-91.3
Acquisitions46.8-218.40.00.0-100.7-125.5-96.7-79.47.0-76.6-14.2-4.4-44.6-72.1-39.4-158.5-89.3
Investments-1,002.1-669.3-1,276.6-689.0-2,060.2-1,305.1-345.1-450.8-370.8-282.7-278.1-294.5-205.7-386.7-683.8-509.3-240.3
Sales of Investment654.862.01,305.3361.31,066.0766.9368.1331.50.3299.8219.9249.5196.1565.8458.3384.6207.6
Other Investing Activities469.30.00.0504.71.50.1112.488.3306.4-0.90.0-4.10.21.26.33.2-3.2
Cash from Investing-11.30.00.020.2-1,207.6-784.4-60.3-208.9-187.0-175.6-213.9-166.9-190.5-5.4-412.8-383.4-216.5
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-45.8-31.7-45.7-34.4-42.9-40.2-42.3-40.2-42.2-44.1
Acquisitions0.0-1.8-216.60.00.00.00.00.02.644.1
Investments-138.8-223.9-153.2-153.4-222.9-399.1-248.1-406.5-151.5-196.0
Sales of Investment-643.2214.4300.1190.7235.3407.1259.4403.5-238.6230.5
Other Investing Activities0.00.00.00.00.00.00.00.0501.9-44.0
Cash from Investing0.00.00.00.00.00.00.00.072.2-9.5
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-0.50.00.0-0.5-0.5-3.0-426.9-0.6-3.0-0.3-0.3-0.3-0.3-300.2-0.6-226.8-206.7
Debt Issued194.31,374.7-30.7207.71,187.70.01.21.07.40.8-1.20.3-1.23.52.3-4.91,171.0
Issuance of Common Stock19.20.00.00.069,585.935,282.00.03,831.00.07.311.38.215.111.210.614.212.7
Repurchase of Common Stock-327.1-295.5-203.6-428.7-215.7-50.0-100.0-28.0-48.9-2.90.00.00.00.0-0.10.00.0
Dividends Paid-85,454.80.00.00.0-68,184.0-35,282.00.0-3,831.00.0-4.40.00.00.00.0-10.50.00.0
Other Financing Activities85,428.30.00.03.5-212.1-2.43.95.93.20.7-2.00.6-3.1-22.713.2-1.0422.7
Cash from Financing-323.20.00.0-425.6973.6-55.4-523.0-22.8-48.70.39.08.611.7-311.712.6-213.6228.7
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-0.1-0.1
Debt Issued1,395.3-11.237.0-5.2-13.4-4.6-7.1-6.2206.80.4
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.0-53.4-140.2-101.90.0-97.8-101.0-4.7-200.0-21.3
Dividends Paid0.00.00.00.00.00.00.00.0-85,439.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.5-5.2
Cash from Financing0.00.00.00.00.00.00.00.0-200.6-26.6
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash17.240.385.4-30.2-36.6-196.04.5228.549.2-72.4-1.344.381.7-131.8-110.8-332.3256.6
Closing Cash Balance407.3532.2489.8404.4434.5471.1667.1662.7434.2383.8456.3457.5413.3331.6463.4574.2906.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash132.026.5-151.433.377.64.5-26.029.4-54.067.8
Closing Cash Balance529.8398.2371.7523.1489.8412.2407.7433.8404.0458.3
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow176.8374.6266.2218.380.3535.7476.4359.4155.7-11.274.972.8136.861.8124.7156.5134.6
Real Free Cash Flow114.4374.6203.9157.019.4484.5434.8323.8127.9-34.655.255.8121.948.1111.5145.8124.4
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow119.189.270.895.581.2100.055.429.638.853.6
Real Free Cash Flow119.189.286.180.264.884.440.414.322.637.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E9.432.9179.3
P/S2.83.4390.6
P/B1.11.7113.4
P/FCF19.166.1149.9
Market cap$8.3$8.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %12.3 %0 %
Debt to Income183.6 %311.9 %0 %
Debt to Free cash flow372.5 %664.8 %0 %
Interest expense percentage21.4 %15.2 %11.2 %
Current ratio5.4 4.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE11.3 %5.5 %0 %
ROA7.8 %3.8 %0 %
CapEx to Revenue6.1 %5.4 %6 %
RaD to Revenue0 %9.4 %0 %
ROEM2,719,157.9 727945.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin51.9 %55.1 %61.9 %
Operating margin8.9 %10.2 %17.9 %
Net margin29.4 %14 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %77 %0 %
Dividend payout percentage0 %-2033 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding27.0 mil 29.2 mil
Employee count1.0 tis 5.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader